Helus Pharma partners with TARA Mind for veteran mental health outreach
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health
April 28, 2026 7:30 AM EDTCollaboration with leading mental health organization to support HLP003 Phase 3 recruitment and expand outreach in veteran communities following landmark Executive Order on breakthrough mental health treatments
NEW YORK & TORONTO, April 28, 2026 (GLOBE NEWSWIRE) -- Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP), a clinical stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (NSAs), today announced a collaboration with TARA Mind, which works with Veterans Exploring Treatment Solutions (VETS) to support clinical trial recruitment for its PARADIGM HLP003 Phase 3 program for Major... More
